Trial intelligence / Profile preview

Vitamin E Supplementation in Oral Lichen Planus

NCT04126720Phase 1Completed

Sponsor
Cairo University
Start
Jan 2016
Primary completion
Apr 2017
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in oral lichen planus (OLP) comparing Vitamin E Group with Placebo Group (2 arms). Primary endpoint: Pain Intensity (NRS) at 4 weeks. Started Jan 2016; status: completed.

02

Drugs

vitamin e
03

Conditions

oral lichen planus (OLP)

Beyond the preview

Go deeper on NCT04126720.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04126720.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call